Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Huntington Disease | 13 | 2022 | 143 | 2.140 |
Why?
|
| Nerve Tissue Proteins | 13 | 2024 | 1132 | 1.090 |
Why?
|
| Huntingtin Protein | 13 | 2022 | 64 | 1.030 |
Why?
|
| Drosophila melanogaster | 14 | 2025 | 843 | 0.870 |
Why?
|
| tau Proteins | 6 | 2025 | 236 | 0.780 |
Why?
|
| Drosophila | 20 | 2025 | 824 | 0.770 |
Why?
|
| Alzheimer Disease | 8 | 2025 | 857 | 0.630 |
Why?
|
| Nuclear Proteins | 7 | 2016 | 1284 | 0.600 |
Why?
|
| Spinocerebellar Ataxias | 6 | 2022 | 255 | 0.590 |
Why?
|
| Drosophila Proteins | 7 | 2025 | 770 | 0.560 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 79 | 0.540 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 109 | 0.540 |
Why?
|
| Tauopathies | 3 | 2024 | 74 | 0.500 |
Why?
|
| alpha-Synuclein | 4 | 2025 | 129 | 0.490 |
Why?
|
| Disease Models, Animal | 21 | 2025 | 4690 | 0.480 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 589 | 0.450 |
Why?
|
| Neurons | 9 | 2023 | 2008 | 0.440 |
Why?
|
| Ataxin-1 | 7 | 2022 | 162 | 0.420 |
Why?
|
| Parkinson Disease | 4 | 2025 | 738 | 0.400 |
Why?
|
| Animals | 36 | 2025 | 34842 | 0.380 |
Why?
|
| Neurodegenerative Diseases | 2 | 2022 | 280 | 0.370 |
Why?
|
| Brain | 9 | 2025 | 3183 | 0.350 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 3 | 2015 | 49 | 0.340 |
Why?
|
| Myotonic Dystrophy | 2 | 2013 | 149 | 0.310 |
Why?
|
| Neuropeptides | 1 | 2009 | 117 | 0.300 |
Why?
|
| RNA Interference | 5 | 2019 | 515 | 0.300 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2021 | 100 | 0.280 |
Why?
|
| Peptides | 6 | 2022 | 844 | 0.280 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 2 | 2021 | 37 | 0.270 |
Why?
|
| Cerebellum | 2 | 2022 | 462 | 0.270 |
Why?
|
| Transcription Factors | 4 | 2021 | 2490 | 0.260 |
Why?
|
| Corpus Striatum | 6 | 2022 | 95 | 0.250 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 607 | 0.250 |
Why?
|
| Autophagy | 2 | 2021 | 426 | 0.250 |
Why?
|
| Friedreich Ataxia | 2 | 2016 | 48 | 0.240 |
Why?
|
| Ubiquitin | 1 | 2006 | 141 | 0.240 |
Why?
|
| Proteolysis | 2 | 2017 | 195 | 0.240 |
Why?
|
| Animals, Genetically Modified | 7 | 2023 | 340 | 0.240 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2006 | 128 | 0.230 |
Why?
|
| Cells, Cultured | 6 | 2021 | 3046 | 0.220 |
Why?
|
| Gene Regulatory Networks | 3 | 2021 | 386 | 0.220 |
Why?
|
| Mice | 18 | 2024 | 18504 | 0.220 |
Why?
|
| Cell Line | 6 | 2021 | 2724 | 0.210 |
Why?
|
| Fibroblasts | 2 | 2018 | 862 | 0.210 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 375 | 0.210 |
Why?
|
| Haploinsufficiency | 1 | 2025 | 268 | 0.200 |
Why?
|
| Neuroglia | 2 | 2023 | 213 | 0.190 |
Why?
|
| Amyloid beta-Peptides | 2 | 2025 | 229 | 0.190 |
Why?
|
| ras Proteins | 2 | 2013 | 146 | 0.190 |
Why?
|
| Transcriptome | 4 | 2025 | 1125 | 0.180 |
Why?
|
| Electrical Synapses | 1 | 2021 | 13 | 0.170 |
Why?
|
| Ataxins | 4 | 2013 | 114 | 0.170 |
Why?
|
| Apolipoprotein E2 | 1 | 2020 | 15 | 0.170 |
Why?
|
| Mutation | 9 | 2024 | 6243 | 0.170 |
Why?
|
| Apolipoprotein E4 | 1 | 2020 | 47 | 0.170 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 1980 | 0.170 |
Why?
|
| Brain Stem | 1 | 2021 | 119 | 0.160 |
Why?
|
| Humans | 34 | 2025 | 132201 | 0.160 |
Why?
|
| Behavior, Animal | 3 | 2021 | 506 | 0.160 |
Why?
|
| Proteomics | 2 | 2016 | 596 | 0.160 |
Why?
|
| Mice, Transgenic | 7 | 2024 | 2449 | 0.160 |
Why?
|
| Cell Nucleus | 2 | 2016 | 592 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2025 | 3356 | 0.150 |
Why?
|
| Protein Kinase C beta | 1 | 2019 | 20 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 398 | 0.150 |
Why?
|
| Sex Factors | 1 | 2023 | 1354 | 0.150 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 332 | 0.150 |
Why?
|
| Protein Kinases | 2 | 2019 | 331 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2018 | 217 | 0.150 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2019 | 133 | 0.140 |
Why?
|
| Models, Biological | 2 | 2017 | 1445 | 0.140 |
Why?
|
| Amyloidosis | 1 | 2019 | 73 | 0.140 |
Why?
|
| DNA Damage | 1 | 2021 | 511 | 0.140 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2017 | 29 | 0.140 |
Why?
|
| Muscles | 2 | 2009 | 239 | 0.140 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2016 | 16 | 0.130 |
Why?
|
| Oxidative Stress | 3 | 2016 | 801 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2024 | 1595 | 0.120 |
Why?
|
| Antioxidants | 2 | 2016 | 333 | 0.120 |
Why?
|
| Dynamin I | 1 | 2015 | 2 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 408 | 0.120 |
Why?
|
| Genome | 1 | 2018 | 504 | 0.120 |
Why?
|
| Repressor Proteins | 2 | 2016 | 812 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2014 | 117 | 0.110 |
Why?
|
| Phosphorylation | 4 | 2021 | 1611 | 0.110 |
Why?
|
| Introns | 1 | 2015 | 305 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 258 | 0.100 |
Why?
|
| Sirolimus | 1 | 2015 | 241 | 0.100 |
Why?
|
| Iron | 1 | 2016 | 302 | 0.100 |
Why?
|
| Genomics | 2 | 2023 | 1652 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 304 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 200 | 0.090 |
Why?
|
| Diacylglycerol Kinase | 1 | 2012 | 15 | 0.090 |
Why?
|
| Phenotype | 2 | 2020 | 4538 | 0.090 |
Why?
|
| HEK293 Cells | 3 | 2021 | 799 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1882 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2016 | 1049 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2025 | 2851 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 63 | 0.080 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 3691 | 0.080 |
Why?
|
| Ganglia | 1 | 2009 | 15 | 0.080 |
Why?
|
| Transgenes | 2 | 2013 | 335 | 0.080 |
Why?
|
| Neurosecretory Systems | 1 | 2009 | 22 | 0.080 |
Why?
|
| Signal Transduction | 4 | 2021 | 4720 | 0.080 |
Why?
|
| Neurites | 1 | 2009 | 45 | 0.080 |
Why?
|
| Genome-Wide Association Study | 3 | 2025 | 1830 | 0.080 |
Why?
|
| Mushroom Bodies | 1 | 2009 | 49 | 0.080 |
Why?
|
| Larva | 1 | 2009 | 259 | 0.080 |
Why?
|
| Neurotransmitter Agents | 1 | 2009 | 143 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 382 | 0.070 |
Why?
|
| Male | 9 | 2025 | 64979 | 0.070 |
Why?
|
| Female | 10 | 2025 | 70754 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2009 | 282 | 0.070 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2007 | 11 | 0.070 |
Why?
|
| Protein Stability | 2 | 2021 | 168 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2021 | 364 | 0.070 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2006 | 12 | 0.060 |
Why?
|
| CELF1 Protein | 1 | 2006 | 48 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2006 | 252 | 0.060 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2006 | 59 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 136 | 0.060 |
Why?
|
| Iron-Binding Proteins | 2 | 2016 | 33 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2025 | 3414 | 0.060 |
Why?
|
| Aging | 2 | 2023 | 1251 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2006 | 173 | 0.060 |
Why?
|
| Protein Folding | 1 | 2006 | 223 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 469 | 0.060 |
Why?
|
| Eye | 1 | 2006 | 235 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2006 | 826 | 0.050 |
Why?
|
| Paralysis | 1 | 2024 | 30 | 0.050 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2023 | 7 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2021 | 2669 | 0.050 |
Why?
|
| Glucosylceramidase | 1 | 2023 | 27 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 689 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 275 | 0.050 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2023 | 18 | 0.050 |
Why?
|
| Mice, Neurologic Mutants | 2 | 2014 | 74 | 0.050 |
Why?
|
| Transglutaminases | 1 | 2022 | 26 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1285 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2024 | 3868 | 0.050 |
Why?
|
| Motor Activity | 2 | 2015 | 523 | 0.050 |
Why?
|
| Lysosomes | 1 | 2023 | 261 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 4758 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 2021 | 109 | 0.040 |
Why?
|
| Locomotion | 1 | 2021 | 61 | 0.040 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2021 | 81 | 0.040 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2021 | 83 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 651 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2006 | 2679 | 0.040 |
Why?
|
| Gene Expression | 2 | 2015 | 1563 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 96 | 0.040 |
Why?
|
| Mitochondria | 2 | 2016 | 749 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 69 | 0.040 |
Why?
|
| Homozygote | 1 | 2020 | 548 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 577 | 0.040 |
Why?
|
| Heterozygote | 1 | 2020 | 715 | 0.040 |
Why?
|
| Species Specificity | 1 | 2018 | 542 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2021 | 906 | 0.030 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2016 | 36 | 0.030 |
Why?
|
| Aluminum | 1 | 2016 | 14 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 302 | 0.030 |
Why?
|
| Manganese | 1 | 2016 | 58 | 0.030 |
Why?
|
| Copper | 1 | 2016 | 75 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 423 | 0.030 |
Why?
|
| Zinc | 1 | 2016 | 125 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2016 | 123 | 0.030 |
Why?
|
| Aconitate Hydratase | 1 | 2015 | 12 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2015 | 52 | 0.030 |
Why?
|
| Aldehydes | 1 | 2015 | 31 | 0.030 |
Why?
|
| Thioxanthenes | 1 | 2014 | 2 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2014 | 12 | 0.030 |
Why?
|
| Fear | 1 | 2016 | 205 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2014 | 38 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1033 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1901 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 126 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 176 | 0.030 |
Why?
|
| Morpholines | 1 | 2014 | 67 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2019 | 720 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 221 | 0.030 |
Why?
|
| Glutathione | 1 | 2015 | 200 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 182 | 0.030 |
Why?
|
| Longevity | 1 | 2015 | 159 | 0.030 |
Why?
|
| NEDD8 Protein | 1 | 2013 | 12 | 0.030 |
Why?
|
| Cullin Proteins | 1 | 2013 | 14 | 0.030 |
Why?
|
| Ubiquitins | 1 | 2013 | 43 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2014 | 449 | 0.020 |
Why?
|
| Farnesyltranstransferase | 1 | 2012 | 8 | 0.020 |
Why?
|
| Myoblasts | 1 | 2013 | 37 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 1080 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 481 | 0.020 |
Why?
|
| Caspase 7 | 1 | 2012 | 9 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 1099 | 0.020 |
Why?
|
| Aged | 2 | 2025 | 21456 | 0.020 |
Why?
|
| Homeostasis | 1 | 2016 | 722 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2012 | 140 | 0.020 |
Why?
|
| Triazoles | 1 | 2012 | 147 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 198 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 309 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 3015 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 673 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 440 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 535 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 679 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 403 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 161 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 10944 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 242 | 0.020 |
Why?
|
| Caspases | 1 | 2010 | 166 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2012 | 418 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 246 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 623 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 996 | 0.020 |
Why?
|
| Adult | 2 | 2023 | 31600 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3771 | 0.020 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2007 | 17 | 0.020 |
Why?
|
| Genes, Insect | 1 | 2007 | 126 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2007 | 251 | 0.020 |
Why?
|
| Genome, Human | 1 | 2012 | 1331 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 502 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2442 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 1350 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 7557 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 29007 | 0.010 |
Why?
|